BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9885302)

  • 1. Altered pharmacokinetics of halofantrine by an antacid, magnesium carbonate.
    Aideloje SO; Onyeji CO; Ugwu NC
    Eur J Pharm Biopharm; 1998 Nov; 46(3):299-303. PubMed ID: 9885302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers.
    Omoruyi SI; Onyeji CO; Daniyan MO
    Ther Drug Monit; 2007 Apr; 29(2):203-6. PubMed ID: 17417075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
    Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
    Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of magnesium trisilicate on nitrofurantoin absorption.
    Naggar VF; Khalil SA
    Clin Pharmacol Ther; 1979 Jun; 25(6):857-63. PubMed ID: 36251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.
    Healy DP; Sahai JV; Sterling LP; Racht EM
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1994-7. PubMed ID: 2610509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
    Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
    Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of kolanut on the pharmacokinetics of the antimalarial drug halofantrine.
    Kolade YT; Babalola CP; Olaniyi AA; Scriba GK
    Eur J Clin Pharmacol; 2008 Jan; 64(1):77-81. PubMed ID: 17952423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers.
    Bassi PU; Onyeji CO; Ukponmwan OE
    Br J Clin Pharmacol; 2004 Jul; 58(1):52-5. PubMed ID: 15206992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antidiabetics-antacid interactions.
    Naggar VF; Khalil SA
    Pharmazie; 1980; 35(7):412-6. PubMed ID: 7413713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion-pair reversed-phase high-performance liquid chromatographic analysis of halofantrine and desbutylhalofantrine in human plasma.
    Onyeji CO; Aideloje SO
    Ther Drug Monit; 1997 Dec; 19(6):682-7. PubMed ID: 9421111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
    Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
    Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers.
    Babalola CP; Kolade YT; Olaniyi AA; Adedapo A; Scriba GK
    J Clin Pharm Ther; 2009 Dec; 34(6):677-82. PubMed ID: 20175801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
    Desager JP; Harvengt C
    J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole.
    Khoo SM; Porter JH; Edwards GA; Charman WN
    J Pharm Sci; 1998 Dec; 87(12):1538-41. PubMed ID: 10189263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro adsorption of some antibiotics on antacids.
    Khalil SA; Daabis NA; Naggar VF; Motawi MM
    Pharmazie; 1976; 31(2):105-9. PubMed ID: 8784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an aluminium-hydroxide containing antacid on the oral bioavailability of pirenzepine.
    Vergin H; Herrlinger C; Gugler R
    Arzneimittelforschung; 1989 Apr; 39(4):520-3. PubMed ID: 2751741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of halofantrine in man: effects of food and dose size.
    Milton KA; Edwards G; Ward SA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jul; 28(1):71-7. PubMed ID: 2775616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antacids on phenytoin bioavailability.
    Carter BL; Garnett WR; Pellock JM; Stratton MA; Howell JR
    Ther Drug Monit; 1981; 3(4):333-40. PubMed ID: 7336470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.